EMG
IMNM icon

ETF Managers Group’s Immunome IMNM Stock Holding History

ETF Managers Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,670
Closed -$20K – 802
2022
Q1 		$20K Buy
3,670
+12
+0.3% +$90 ﹤0.01% 687
2021
Q4 		$51K Sell
3,658
-542
-13% -$9.67K ﹤0.01% 666
2021
Q3 		$101K Buy
4,200
+729
+21% +$12.7K ﹤0.01% 640
2021
Q2 		$61K Buy
3,471
+221
+7% +$4.88K ﹤0.01% 634
2021
Q1 		$100K Buy
+3,250
New +$80.8K ﹤0.01% 637

Other funds holding IMNM

PCM
Prentice Capital Management Greenwich, Connecticut $52.9M AUM 2.04% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

ETF Managers Group's IMNM Position: Q2 2022 in Review

ETF Managers Group sold out of Immunome (IMNM) in Q2 2022, closing a stake of 3,670 shares — an estimated $20K sold.

ETF Managers Group first reported a position in IMNM in Q1 2021 and held it in 5 quarters. The position peaked at $101K in Q3 2021. 26 funds tracked by Wall St. Rank hold IMNM as of Q2 2022.

  • ETF Managers Group reported no remaining Immunome position as of Q2 2022 after selling out during the quarter.
  • ETF Managers Group sold 3,670 Immunome shares in Q2 2022, an estimated $20K.
  • ETF Managers Group first reported a position in Immunome in Q1 2021 and held it in 5 quarters.
  • ETF Managers Group's Immunome position peaked at $101K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Immunome as of Q2 2022.

Based on ETF Managers Group's 13F filing for Q2 2022, filed 15 Aug 2022.